Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-08-22 00:00:00 ET · period of report 2022-08-18 · accession 0001209191-22-047031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-22 | 2022-08-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 45.3K | +7% | +$16.6K |
| DM | 2022-08-22 | 2022-08-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $25.26 | -3,100 | 42.2K | -7% | -$78.3K |
| D | 2022-08-22 | 2022-08-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $0.00 | -3,100 | 493.6K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-18 | M | A | 3,100 | $5.35 | 45,287 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-18 | S | D | 2,551 | $25.13 | 42,736 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $24.615 to $25.52. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-08-18 | S | D | 549 | $25.89 | 42,187 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $25.71 to $26.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (right to buy) | 2022-08-18 | M | D | 3,100 | $0.00 | 493,618 | D | $5.35 · — to 2030-05-11 | 3,100 Common Stock | (F4) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |